Vitamin D attenuates rhinovirus-induced expression of intercellular adhesion molecule-1 (ICAM-1) and platelet-activating factor receptor (PAFR) in respiratory epithelial cells
暂无分享,去创建一个
David A. Jolliffe | S. Johnston | T. Kebadze | A. Martineau | R. Suri | C. Greiller | C. Griffiths | A. Hirsman | Reetika Suri
[1] Mitsuyoshi Urashima,et al. Vitamin D supplementation to prevent asthma exacerbations: a systematic review and meta-analysis of individual participant data. , 2017, The Lancet. Respiratory medicine.
[2] David A. Jolliffe,et al. Vitamin D for the management of asthma. , 2023, The Cochrane database of systematic reviews.
[3] David A. Jolliffe,et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data , 2017, British Medical Journal.
[4] S. Johnston,et al. Vitamin D increases the antiviral activity of bronchial epithelial cells in vitro , 2017, Antiviral research.
[5] David A. Jolliffe,et al. Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial. , 2015, The Lancet. Respiratory medicine.
[6] J. Gern,et al. Effects of Vitamin D on Airway Epithelial Cell Morphology and Rhinovirus Replication , 2014, PloS one.
[7] Q. Hu,et al. Differential response to 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3) in non-small cell lung cancer cells with distinct oncogene mutations , 2013, The Journal of Steroid Biochemistry and Molecular Biology.
[8] Jie Du,et al. Vitamin D Receptor Inhibits Nuclear Factor κB Activation by Interacting with IκB Kinase β Protein* , 2013, The Journal of Biological Chemistry.
[9] M. Decramer,et al. High Doses of Vitamin D to Reduce Exacerbations in Chronic Obstructive Pulmonary Disease , 2012, Annals of Internal Medicine.
[10] D. Davidson,et al. Antiviral Activity and Increased Host Defense against Influenza Infection Elicited by the Human Cathelicidin LL-37 , 2011, PloS one.
[11] P. DePetrillo,et al. Serum 25-Hydroxyvitamin D and the Incidence of Acute Viral Respiratory Tract Infections in Healthy Adults , 2010, PloS one.
[12] S. Johnston,et al. Azithromycin induces anti-viral responses in bronchial epithelial cells , 2010, European Respiratory Journal.
[13] G. Hunninghake,et al. Vitamin D Decreases Respiratory Syncytial Virus Induction of NF-κB–Linked Chemokines and Cytokines in Airway Epithelium While Maintaining the Antiviral State , 2009, The Journal of Immunology.
[14] C. Camargo,et al. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. , 2009, Archives of internal medicine.
[15] G. Hunninghake,et al. Respiratory Epithelial Cells Convert Inactive Vitamin D to Its Active Form: Potential Effects on Host Defense1 , 2008, The Journal of Immunology.
[16] A. Bonanomi,et al. Vitamin D derivatives induce apoptosis and downregulate ICAM‐1 levels in peripheral blood mononuclear cells of inflammatory bowel disease patients , 2008, Inflammatory bowel diseases.
[17] S. Johnston,et al. Pathophysiology of viral-induced exacerbations of COPD , 2007, International journal of chronic obstructive pulmonary disease.
[18] R. Wilkinson,et al. Neutrophil-mediated innate immune resistance to mycobacteria. , 2007, The Journal of clinical investigation.
[19] Robert J Wilkinson,et al. IFN-γ- and TNF-Independent Vitamin D-Inducible Human Suppression of Mycobacteria: The Role of Cathelicidin LL-371 , 2007, The Journal of Immunology.
[20] W. Busse,et al. The role of rhinovirus in asthma exacerbations. , 2005, The Journal of allergy and clinical immunology.
[21] H. Koeffler,et al. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up‐regulated in myeloid cells by 1,25‐dihydroxyvitamin D3 , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] G. Kärber,et al. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche , 1931, Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie.
[23] F. Hayden. Rhinovirus and the lower respiratory tract† , 2004, Reviews in medical virology.
[24] N. Papadopoulos. Do rhinoviruses cause pneumonia in children? , 2004, Paediatric respiratory reviews.
[25] S. Ishizuka,et al. Effects of rhinovirus infection on the adherence of Streptococcus pneumoniae to cultured human airway epithelial cells. , 2003, The Journal of infectious diseases.
[26] S. Johnston,et al. Rhinovirus Infection Induces Expression of Its Own Receptor Intercellular Adhesion Molecule 1 (ICAM-1) via Increased NF-κB-mediated Transcription* , 1999, The Journal of Biological Chemistry.
[27] G. L. Kirkpatrick. THE COMMON COLD , 1996, Primary Care: Clinics in Office Practice.
[28] E. Tuomanen,et al. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor , 1995, Nature.
[29] A. Monto. Studies of the Community and Family: Acute Respiratory Illness and Infection , 1994, Epidemiologic reviews.
[30] D. Staunton,et al. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses , 1989, Cell.
[31] C. Spearman,et al. The method of 'right and wrong cases' ('constant stimuli') without Gauss's formulae , 1908 .